Feinberg investigators are conducting basic science research, epidemiological studies and drug trials of new therapies for food allergies to uncover the breadth of the problem, understand the basic cellular pathways and develop new avenues of treatment.
Northwestern Medicine investigators discovered a method to modulate levels of a protein that is known to drive inflammation, by manipulating levels of an amino acid known as serine.
Most patients who report a penicillin allergy are in fact not allergic, and verifying allergies before resorting to less-effective antibiotics can improve outcomes and avoid the spread of antimicrobial resistance, according to a review in JAMA.
Men with inflammatory bowel disease have four to five times higher risk of prostate cancer, according to a new 20-year study.
Inflammation has unexpected effects on body clock function and can lead to sleep and shiftwork-type disorders, according to a new study.
A new Northwestern Medicine study has identified a trigger of some fibrotic diseases and an experimental compound to treat it.
Infant and childhood food allergy, whose cause has long been a mystery, has now been linked to a mix of environmental and genetic factors that must coexist to trigger the allergy, reports a new Northwestern Medicine study.
A new study demonstrates how physicians can use genetic profiling of joint tissue to see which drugs will work for which patients.
A drug originally designed for chemotherapy may reduce allergic responses for a variety of allergens, according to a study published in the Journal of Allergy and Clinical Immunology.
Northwestern Medicine scientists have identified a guardian molecule triggered by testosterone that appears to protect males from multiple sclerosis.